Does ELACESTRANT Cause Hepatic lesion? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Hepatic lesion have been filed in association with ELACESTRANT (ORSERDU). This represents 0.2% of all adverse event reports for ELACESTRANT.
11
Reports of Hepatic lesion with ELACESTRANT
0.2%
of all ELACESTRANT reports
0
Deaths
4
Hospitalizations
How Dangerous Is Hepatic lesion From ELACESTRANT?
Of the 11 reports, 4 (36.4%) required hospitalization.
Is Hepatic lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELACESTRANT. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ELACESTRANT Cause?
Nausea (1,454)
Fatigue (1,081)
Disease progression (777)
Vomiting (662)
Diarrhoea (540)
Death (499)
Drug ineffective (478)
Constipation (389)
Product dose omission issue (364)
Decreased appetite (363)
What Other Drugs Cause Hepatic lesion?
OCTREOTIDE (296)
EVEROLIMUS (171)
RIBOCICLIB (144)
LETROZOLE (139)
CAPECITABINE (124)
ADALIMUMAB (123)
METHOTREXATE (108)
FULVESTRANT (107)
PALBOCICLIB (104)
CYCLOPHOSPHAMIDE (101)
Which ELACESTRANT Alternatives Have Lower Hepatic lesion Risk?
ELACESTRANT vs ELAFIBRANOR
ELACESTRANT vs ELAGOLIX
ELACESTRANT vs ELAGOLIX\ESTRADIOL\NORETHINDRONE
ELACESTRANT vs ELAPEGADEMASE-LVLR
ELACESTRANT vs ELASOMERAN